What to expect from JAK inhibitor therapy for vitiligo

Vitiligo occurs when pigment-producing cells are lost or become inactive in affected skin. JAK inhibition can reduce immune signalling involved in that process. If pigment returns, it may begin around hair follicles or at the edges of a patch and develop unevenly. Areas such as the face may respond differently from hands, feet, or other body sites. Colour can continue to change over time, so photographs taken in consistent lighting can help show gradual progress.

Apply or take the treatment exactly as prescribed, depending on the formulation. Protect depigmented skin from sunburn with shade, clothing, and sunscreen, because affected areas have less natural pigment. Keep appointments for skin review and tell your clinician about infections, new medicines, pregnancy plans, or vaccination questions. Avoid judging progress from day to day; compare changes at the intervals your care team recommends.

Report severe irritation, spreading redness, painful skin, fever, or a new persistent cough promptly. Seek urgent help for breathing difficulty, facial or throat swelling, chest pain, or sudden weakness. Also contact your dermatologist if the treated area develops a rapidly changing pattern, because the diagnosis and treatment plan may need review.

Ask which body areas are suitable for the treatment, how repigmentation will be photographed or assessed, how long a trial should be reviewed, and whether other treatments can be combined. Discuss sun protection, missed applications, infection precautions, pregnancy, and what changes should prompt a call.